Amedisys Inc (AMED)
Debt-to-capital ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | 361,900 | 419,400 | 432,100 | 204,500 | 232,256 |
| Total stockholders’ equity | US$ in thousands | 1,066,510 | 1,051,570 | 931,351 | 809,224 | 640,450 |
| Debt-to-capital ratio | 0.25 | 0.29 | 0.32 | 0.20 | 0.27 |
December 31, 2023 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $361,900K ÷ ($361,900K + $1,066,510K)
= 0.25
Amedisys Inc.'s debt-to-capital ratio has shown fluctuations over the past five years. The ratio decreased from 0.27 in 2019 to 0.21 in 2020, indicating a lower reliance on debt in financing its operations relative to its capital structure. However, the ratio increased to 0.32 by the end of 2021, suggesting a higher proportion of debt used compared to capital.
In 2022, there was a slight improvement as the debt-to-capital ratio decreased to 0.29, but it remained higher than the 2020 level. By the end of 2023, the ratio slightly improved again to 0.27, signaling a moderate reliance on debt in the capital structure of Amedisys Inc.
Overall, Amedisys Inc.'s debt-to-capital ratio has fluctuated within the range of 0.21 to 0.32 over the past five years, indicating variability in the company's debt management and capital structure decisions. Further analysis of the company's financial health and management of debt levels would be necessary to provide deeper insights into the implications of these fluctuations on the company's operations and financial stability.
Peer comparison
Dec 31, 2023